Resveratrol supplement reduced NLRP3 inflammasome activity, decreased TGF-β1 production, and downregulated the p-SMAD2/SMAD2 expression in a rat model of acute myocardial infarction, thus protecting the heart against cardiac fibrosis [162]. This evidence concerns the gene SMAD2 and myocardial infarction.